Gene · 6495
Papers2,008
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,008
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Astrocyte Immune Functions and Glaucoma. | Int J Mol Sci | 2023 | 36769067 | PubTator, text mining | PubMed |
| The Role of Cytokines in Epithelial-Mesenchymal Transition in Gynaecological Cancers: A Systematic Review. | Cells | 2023 | 36766756 | PubTator, text mining | PubMed |
| Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. | Cell Biosci | 2023 | 36755301 | PubTator, text mining | PubMed |
| Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry. | Cancer Metastasis Rev | 2023 | 36754910 | PubTator, text mining | PubMed |
| Retinal determination gene networks: from biological functions to therapeutic strategies. | Biomark Res | 2023 | 36750914 | PubTator, text mining | PubMed |
| A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. | Comput Struct Biotechnol J | 2023 | 36733702 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer. | J Oncol | 2023 | 36733672 | PubTator, text mining | PubMed |
| Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine. | Front Pharmacol | 2023 | 36733504 | PubTator, text mining | PubMed |
| Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin. | PLoS One | 2023 | 36689432 | PubTator, text mining | PubMed |
| Controlling human organoid symmetry breaking reveals signaling gradients drive segmentation clock waves. | Cell | 2023 | 36657441 | PubTator, text mining | PubMed |
| SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm. | Cell Death Dis | 2023 | 36639679 | PubTator, text mining | PubMed |
| Identity, lineage and fates of a temporally distinct progenitor population in the embryonic olfactory epithelium. | Dev Biol | 2023 | 36627077 | PubTator, text mining | PubMed |
| Breast cancer heterogeneity and its implication in personalized precision therapy. | Exp Hematol Oncol | 2023 | 36624542 | PubTator, text mining | PubMed |
| Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer. | Cell Death Dis | 2023 | 36624091 | PubTator, text mining | PubMed |
| Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review). | Int J Oncol | 2023 | 36579676 | PubTator, text mining | PubMed |
| Self-Assembled Matrigel-Free iPSC-Derived Liver Organoids Demonstrate Wide-Ranging Highly Differentiated Liver Functions. | Stem Cells | 2023 | 36573434 | PubTator, text mining | PubMed |
| Clinically diverse and perinatally lethal syndromes with urorectal septum malformation sequence. | Am J Med Genet A | 2023 | 36478354 | PubTator, text mining | PubMed |
| Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | Mol Cancer Res | 2023 | 36306210 | PubTator, text mining | PubMed |
| A perspective to weaponize microRNAs against lung cancer. | Noncoding RNA Res | 2023 | 36262424 | PubTator, text mining | PubMed |
| SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16. | Acta Pharmacol Sin | 2023 | 36261513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6495/papers?page=16